2-Nonanone, 3-(hydroxymethyl)-
Common Name: |
2-Nonanone, 3-(hydroxymethyl)- |
IUPAC Name: |
3-(hydroxymethyl)nonan-2-one |
Molecular Formula: |
C10H20O2 |
SMILES: |
CCCCCCC(CO)C(=O)C |
Inchi: |
1S/C10H20O2/c1-3-4-5-6-7-10(8-11)9(2)12/h10-11H,3-8H2,1-2H3 |
Inchi Key: |
DIZUHEORFPDTIQ-UHFFFAOYSA-N |
Cas No: |
67801-33-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
172.26 |
Mass (g/mol) |
172.146 |
Molar Refractivity |
51.55 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
7 |
Rings |
|
TPSA |
37.30 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
-5.80 @ 0.00 mm Hg |
Boiling Point (°C@760.00mm Hg) |
378.00 @ 0.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.001 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.90 |
LogP |
2.154 |
iLOGP |
2.50 |
XLOGP3 |
2.29 |
WLOGP |
2.15 |
MLOGP |
1.77 |
ESOL Log S |
-1.89 |
ESOL Solubility (mg/ml) |
2.23 |
ESOL Solubility (mol/l) |
0.013 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.71 |
Ali Solubility (mg/ml) |
0.34 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.50 |
Silicos-IT Solubility (mg/ml) |
0.54 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.72 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.582 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.686 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |